Work

Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a “real world” study

Year: 2017

Type: article

Study design: Observational Study

Source: Hematological Oncology

DOI: 10.1002/hon.2380

Authors: Narendranath Epperla, Mehdi Hamadani, Amanda F. Cashen, Kwang W. Ahn, Eunhye Oak, Abraham S. Kanate, Oscar Calzada, Jonathon B. Cohen, Luke Farmer, Nilanjan Ghosh, Michael Tallarico, Chadi Nabhan, Luciano J. Costa, Vaishalee P. Kenkre, Parameswaran N. Hari, Timothy S. Fenske

Institutions: Medical College of Wisconsin, Washington University in St. Louis, West Virginia University, Emory University, Winship Cancer Institute, Carolinas Healthcare System, Levine Cancer Institute, University of Chicago, University of Alabama at Birmingham, University of Wisconsin–Madison

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2569849048

FWCI: 5.159

Cites: 20

Cited by: 70

Related to: 10